Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2017 April;108(2) > Minerva Medica 2017 April;108(2):185-90

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

REVIEW   

Minerva Medica 2017 April;108(2):185-90

DOI: 10.23736/S0026-4806.16.04601-2

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

The effect of prediabetes on hepatocellular carcinoma risk: a systematic review and meta-analysis

Wei-Guo XU, Yun-Feng QIAN, Jun WU

Department of Geriatrics, Guangzhou General Hospital of Guangzhou Military Command, Guangdong, China



INTRODUCTION: Some studies suggested an increased risk of hepatocellular carcinoma (HCC) risk in subjects with prediabetes, whereas other studies have reported negative results. Therefore, we did this meta-analysis to assess the role of prediabetes on HCC risk.
EVIDENCE ACQUISITION: We searched studies from PubMed, Embase, and Web of Science databases. The strength of association between prediabetes and HCC risk was assessed by calculating hazard ratio (HR) with 95% CI.
EVIDENCE SYNTHESIS: A total of 8 cohort studies and 1 case-control study with 1384594 individuals were included. Patients with prediabetes showed an increased HCC risk (HR=1.21; 95% CI, 1.13-1.30; P<0.00001). Subgroup analyses were performed according to race and gender. The results showed that both Asians with prediabetes (HR=1.19; 95% CI, 1.11-1.28; P<0.00001) and Caucasians with prediabetes (HR=2.12; 95% CI, 1.36-3.31; P=0.001 were significantly associated with increased risk of HCC, respectively. In the subgroup analysis by gender, both male patients with prediabetes (HR=1.49; 95% CI, 1.03-2.15; P=0.03) and female patients with prediabetes (HR=1.24; 95% CI, 1.01-1.52; P=0.04) showed increased risk of HCC, respectively.
CONCLUSIONS: In conclusion, this meta-analysis demonstrated that prediabetes might be a risk factor of HCC.


KEY WORDS: Carcinoma, hepatocellular - Prediabetic state - Meta-analysis

inizio pagina